VEGFR-2-IN-53
VEGFR-2-IN-53 (Compound 15w) is a VEGFR-2 inhibitor with an IC50 of 4.34 μM. VEGFR-2-IN-53 induces apoptosis by inhibiting VEGFR-2 activity and preventing cell migration, thereby exhibiting anti-angiogenic effects. The IC50 value of VEGFR-2-IN-53 for inhibiting MCF-7 cell growth is 3.87 μM. VEGFR-2-IN-53 can be used in cancer research[1].
Product Specifications
UNSPSC
12352005
Target
Apoptosis; VEGFR
Type
Reference compound
Related Pathways
Apoptosis; Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/vegfr-2-in-53.html
Smiles
O=C(NC1=NC2=C(C=CC=C2)S1)[C@H]3[C@H](C4=C(C)N(C5=CC=CC=C5)N=C4C)[C@@](C6=CC=CC=C6N7)3C7=O
Molecular Formula
C29H23N5O2S
Molecular Weight
505.59
References & Citations
[1]Valapil DG, et al. Design, development of pyrazole-linked spirocyclopropyl oxindole-carboxamides as potential cytotoxic agents and Type III allosteric VEGFR-2 inhibitors. ChemMedChem. 2024 Aug 1:e202400422.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
VEGFR2/KDR/Flk-1
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7021878-01 0.02 mg
Recombinant Escherichia coli Monofunctional biosynthetic peptidoglycan transglycosylase (mtgA)
Ask
View Details 
MBS7021878-02 0.1 mg
Recombinant Escherichia coli Monofunctional biosynthetic peptidoglycan transglycosylase (mtgA)
Ask
View Details MBS7021878-03 5x 0.1 mg
Recombinant Escherichia coli Monofunctional biosynthetic peptidoglycan transglycosylase (mtgA)
Ask
View Details MBS2904933-01 48 Well
Human SORCS2/VPS10 domain-containing receptor SorCS2 ELISA Kit
Ask
View Details 
MBS2904933-02 96 Well
Human SORCS2/VPS10 domain-containing receptor SorCS2 ELISA Kit
Ask
View Details MBS2904933-03 5x 96 Well
Human SORCS2/VPS10 domain-containing receptor SorCS2 ELISA Kit
Ask
View Details